What You Should Know
- The Launch: ConcertAI has introduced Cadence Suite, an AI-native suite of applications specifically designed for pharmaceutical commercial and field teams to identify and resolve patient access barriers before they disrupt therapy.
- The Core Problem: When patients experience friction in their care journey—such as prior authorization delays, coverage confusion, or pharmacy stockouts—health outcomes suffer and therapy drop-off rates spike.
- The Data Unification: Cadence Suite combats this by unifying specialty pharmacy data, claims data, and social determinants of health (SDOH) into a single, connected view, converting complex information into actionable intelligence.
- The AI Engine: The suite is powered by ConcertAI’s proprietary agentic AI platform, CARA™. It aggregates commercial data and applies automated, real-time quality checks that reduce data errors by up to 25%, establishing a single source of truth for commercial teams.
- The Enterprise ROI: The platform can be fully implemented in as little as 30 days. It provides field reimbursement teams with secure case management tools to triage “stuck” patients, while offering trade and distribution teams predictive alerts for supply risks to prevent missed doses.
